Categories: BioTechITTime
Novel Biotechnology manufactures DNA plasmids using a proprietary bacterial strain. A drop-in replacement for e. coli, it can produce challenging plasmids at higher yield in less time.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 28.09.2023 | Novel Biotechnology Raises $2.5M in Seed Funding | Novel Biotechnology, a Toronto, Canada-based biotechnology startup developing solutions for plasmid DNA production, raised $2.5M in Seed funding.
The round saw participation from angel investors, along with the Ontario Center of Innovation ... |
Reviews 0
